Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid Tumors

NCT02168725 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
26
Enrollment
INDUSTRY
Sponsor class

Stopped The study was placed on hold by the FDA due to manufacturing issues and was not restarted.

Conditions

Interventions

Sponsor

Traws Pharma, Inc.